Literature DB >> 9297536

Parameters affecting the immunogenicity of recombinant T cell epitopes inserted into hybrid proteins.

R Lo-Man1, C Leclerc.   

Abstract

In the past few years a considerable number of studies have focused on the mechanisms of antigen presentation by classical major histocompatibility complex (MHC) class I and class II encoded molecules. Among different approaches, the engineering of recombinant chimeric genes and proteins has provided new tools to analyze the parameters influencing the intracellular processing of antigenic determinants. This review will summarize and discuss the different models of recombinant genes and molecules that have been used to analyze the influence of the molecular environment of a T cell determinant on its efficient processing and MHC presentation. This approach may also represent an interesting tool for developing new vaccine strategies for inducing T cell responses against pathogens.

Mesh:

Substances:

Year:  1997        PMID: 9297536     DOI: 10.1016/s0198-8859(97)00076-1

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  3 in total

1.  Three T-cell determinants of Cry j 1 and Cry j 2, the major Japanese cedar pollen antigens, retain their immunogenicity and tolerogenicity in a linked peptide.

Authors:  Tomomi Yoshitomi; Kazuki Hirahara; Junko Kawaguchi; Nobufusa Serizawa; Yoshifumi Taniguchi; Saburo Saito; Masahiro Sakaguchi; Sakae Inouye; Akio Shiraishi
Journal:  Immunology       Date:  2002-12       Impact factor: 7.397

2.  Identification of novel immunodominant CD4+ Th1-type T-cell peptide epitopes from herpes simplex virus glycoprotein D that confer protective immunity.

Authors:  Lbachir BenMohamed; Georges Bertrand; Cory D McNamara; Helene Gras-Masse; Juergen Hammer; Steven L Wechsler; Anthony B Nesburn
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

3.  Absence of gamma-interferon-inducible lysosomal thiol reductase in melanomas disrupts T cell recognition of select immunodominant epitopes.

Authors:  M Azizul Haque; Ping Li; Sheila K Jackson; Hassane M Zarour; John W Hawes; Uyen T Phan; Maja Maric; Peter Cresswell; Janice S Blum
Journal:  J Exp Med       Date:  2002-05-20       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.